In patients with CAD combined with T2DM, P PARgamma C161 > T genotypes are associated with levels of TG and apo B but not glucose metabolism, with CC homozygote carriers having significantly higher levels of TG and apo B than those in T allele carriers [12]. Here, APOB is linked to type 2 diabetes mellitus.